Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Humbert

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Plos One|January 30, 2014
Lethal giant larvae 1 tumour suppressor activity is not conserved in models of mammalian T and B cell leukaemiaEdwin D Hawkins, Jane Oliaro, Kelly M Ramsbottom, et al.
ACS Chemical Biology|May 10, 2013
Increasing intracellular bioavailable copper selectively targets prostate cancer cellsMichael A Cater, Helen B Pearson, Kamil Wolyniec, et al.
Immunology and Cell Biology|September 23, 2015
Lethal giant larvae-1 deficiency enhances the CD8(+) effector T-cell response to antigen challenge in vivoKelly M Ramsbottom, Faruk Sacirbegovic, Edwin D Hawkins, et al.
Science Advances|February 23, 2022
PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancerPei Kee Goh, Florian Wiede, Mara N Zeissig, et al.
Plos One|January 18, 2017
The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or EnucleationChristina B Wölwer, Nathan Gödde, Luke B Pase, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2019
<sup>18</sup>FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patternsO Humbert, N Cadour, M Paquet, et al.
Plos One|October 3, 2012
Characterization of in vivo Dlg1 deletion on T cell development and functionLisa A Humphries, Meredith H Shaffer, Faruk Sacirbegovic, et al.
Oncogene|March 16, 2022
Correction: TSPAN6 is a suppressor of Ras-driven cancerPatrick O Humbert, Tamara Zoranovic Pryjda, Blanka Pranjic, et al.
Oncogene|February 20, 2022
TSPAN6 is a suppressor of Ras-driven cancerPatrick O Humbert, Tamara Zoranovic Pryjda, Blanka Pranjic, et al.
Nature Communications|May 9, 2013
Regulation of asymmetric cell division and polarity by Scribble is not required for humoral immunityEdwin D Hawkins, Jane Oliaro, Axel Kallies, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Plos One|January 30, 2014
Lethal giant larvae 1 tumour suppressor activity is not conserved in models of mammalian T and B cell leukaemiaEdwin D Hawkins, Jane Oliaro, Kelly M Ramsbottom, et al.
ACS Chemical Biology|May 10, 2013
Increasing intracellular bioavailable copper selectively targets prostate cancer cellsMichael A Cater, Helen B Pearson, Kamil Wolyniec, et al.
Immunology and Cell Biology|September 23, 2015
Lethal giant larvae-1 deficiency enhances the CD8(+) effector T-cell response to antigen challenge in vivoKelly M Ramsbottom, Faruk Sacirbegovic, Edwin D Hawkins, et al.
Science Advances|February 23, 2022
PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancerPei Kee Goh, Florian Wiede, Mara N Zeissig, et al.
Plos One|January 18, 2017
The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or EnucleationChristina B Wölwer, Nathan Gödde, Luke B Pase, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2019
<sup>18</sup>FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patternsO Humbert, N Cadour, M Paquet, et al.
Plos One|October 3, 2012
Characterization of in vivo Dlg1 deletion on T cell development and functionLisa A Humphries, Meredith H Shaffer, Faruk Sacirbegovic, et al.
Oncogene|March 16, 2022
Correction: TSPAN6 is a suppressor of Ras-driven cancerPatrick O Humbert, Tamara Zoranovic Pryjda, Blanka Pranjic, et al.
Oncogene|February 20, 2022
TSPAN6 is a suppressor of Ras-driven cancerPatrick O Humbert, Tamara Zoranovic Pryjda, Blanka Pranjic, et al.
Nature Communications|May 9, 2013
Regulation of asymmetric cell division and polarity by Scribble is not required for humoral immunityEdwin D Hawkins, Jane Oliaro, Axel Kallies, et al.
Pageof 12